Table 2.
Patients characteristics and outcomes in patients with COVID-19
| COVID (+) group I (n = 43) | COVID (+) group II (n = 30) | Total (COVID (+) group I + group II) (n = 73) | Group III (n = 1884) | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|
| Age, years | 55 (43–66) | 50 (10–65) | 56 (45–66) | 52 (38–67) | 0.832 | 0.103 | 0.231 |
| Male, n (%) | 28 (66.7) | 16 (53.3) | 44 (61.1) | 1035 (54.9) | 0.132 | 1.000 | 0.303 |
| ASA classification > 2, n (%) | 7 (16.3) | 13 (43.3) | 20 (27.4) | 35 (1.9) | <0.001 | <0.001 | <0.001 |
| Comorbidities, n (%) | |||||||
| Hypertension | 12 (27.9) | 17 (56.7) | 29 (39.7) | 206 (10.9) | <0.001 | <0.001 | <0.001 |
| DM | 4 (9.3) | 6 (20.0) | 10 (13.7) | 114 (6.1) | 0.353 | 0.006 | 0.007 |
| CRF | 0 (0.0) | 3 (10.0) | 3 (4.1) | 32 (1.7) | 0.394 | 0.007 | 0.121 |
| CAD | 4 (9.3) | 10 (33.3) | 14 (19.2) | 77 (4.1) | 0.083 | 0.001 | <0.001 |
| Immunosuppressive drug | 20 (46.5) | 24 (80.0) | 44 (60.3) | 3 (0.2) | <0.001 | <0.001 | <0.001 |
| COPD | 4 (9.3) | 8 (26.7) | 12 (16.4) | 37 (2.0) | <0.001 | <0.001 | <0.001 |
| Smoking | 16 (37.2) | 5 (16.7) | 21 (28.8) | 318 (16.9) | <0.001 | 1.000 | 0.007 |
| CVA | 0 (0.0) | 2 (6.7) | 2 (2.8) | 18 (0.1) | 0.525 | 0.032 | 0.131 |
| Preoperative COVID (+) patients, n (%) | 39 (90.7) | 28 (93.3) | 67 (88.9) | ||||
| ICU requirement, n (%) | 18 (41.9) | 5 (17.9) | 23 (35.9) | – | – | – | – |
| MV requirement, n (%) | 10 (55.6) | 3 (60.0) | 13 (56.5) | ||||
| MV duration, days | 16 (12–24) | 13 (2–28) | 14 (10–27) | ||||
| LOS-ICU, days | 19 (10–22) | 15 (2–26) | 17 (8–26) | ||||
| LOS-hospital, days | 26 (22–32) | 19 (17–30) | 22 (20–31) | ||||
| Mortality | 1 (2.6) | 1 (3.6) | 2 (3.1) | ||||
| Postoperative COVID (+) patients, n (%) | 4 (9.3) | 2 (6.7) | 6 (8.2) | – | – | – | – |
| ICU requirement, n (%) | 1 (25.0) | 1 (50.0) | 2 (33.3) | ||||
| MV requirement, n (%) | 1 (25.0) | 1 (50.0) | 2 (33.3) | ||||
| Mortality | 0 (0.0) | (0.0) | (0.0) | ||||
| ICU requirement, n (%) | 19 (44.2) | 6 (20.0) | 25 (31.5) | 460 (24.4) | 0.033 | 0.443 | 0.044 |
| Mortality, n (%) | 1 (2.3) | 1 (3.3) | 2 (2.7) | 57 (3.0) | 0.809 | 1.000 | 0.904 |
CAD, coronary arterial disease; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; CVA, cerebrovascular accident; DM, diabetes mellitus; group III, hospitalised COVID patients; ICU, intensive care unit; group II, intervention patients; group I, surgical patients; P1, group I and group III; P2, group II and group III; P3, total and group III.